Watson David O.'s Form 4 filing
Apellis Pharmaceuticals, Inc. (APLS) · filed Dec 23, 2021
- Accession no.
- 0001127602-21-031868
- Filed
- Dec 23, 2021
- Trade date
- Dec 22, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 4 derivative transactions. Open-market sales total $505.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Watson David O.CIK 0001657719 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 | Common Stock | MOption exerciseAcquired | +5,174 | $13.85 | +$71,659.9 | 104,367 | Direct | |
| Dec 22, 2021 | Common Stock | MOption exerciseAcquired | +4,826 | $13.85 | +$66,840.1 | 109,193 | Direct | |
| Dec 22, 2021 | Common Stock | SSaleDisposed | −5,174 | $47.72 | −$246,903.28 | 104,019 | Direct | |
| Dec 22, 2021 | Common Stock | MOption exerciseAcquired | +4,715 | $14.95 | +$70,489.25 | 108,734 | Direct | |
| Dec 22, 2021 | Common Stock | MOption exerciseAcquired | +5,397 | $14.95 | +$80,685.15 | 114,131 | Direct | |
| Dec 22, 2021 | Common Stock | SSaleDisposed | −5,097 | $47.86 | −$243,942.42 | 109,034 | Direct | |
| Dec 22, 2021 | Common Stock | SSaleDisposed | −300 | $48.58 | −$14,574 | 108,734 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 | Common Stock | MOption exerciseDisposed | −5,174 | $0.00 | $0 | 16,493 | Direct | |
| Dec 22, 2021 | Common Stock | MOption exerciseDisposed | −4,826 | $0.00 | $0 | 11,667 | Direct | |
| Dec 22, 2021 | Common Stock | MOption exerciseDisposed | −4,715 | $0.00 | $0 | 20,285 | Direct | |
| Dec 22, 2021 | Common Stock | MOption exerciseDisposed | −5,397 | $0.00 | $0 | 14,888 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.